Company Performance Metrics
- Daniel Powell: CEO
Spark Biomedical develops and provides bioelectric medicine solutions using Transcutaneous Auricular Neurostimulation technology. The company's FDA-cleared product, Sparrow Ascent, is a wearable neurostimulation solution for opioid withdrawal designed to address critical needs where existing treatments may fall short. Spark Biomedical is also
evolving its technology platform to develop new treatments in areas including neurological health, hemostasis, pediatrics, and women's health. This technology serves as an adjunct or alternative to traditional treatments when medication reduction or balancing the autonomic nervous system is necessary for symptom relief.